These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor. Göblyös A; Gao ZG; Brussee J; Connestari R; Santiago SN; Ye K; Ijzerman AP; Jacobson KA J Med Chem; 2006 Jun; 49(11):3354-61. PubMed ID: 16722654 [TBL] [Abstract][Full Text] [Related]
4. Species differences and mechanism of action of A Du L; Gao ZG; Paoletta S; Wan TC; Gizewski ET; Barbour S; van Veldhoven JPD; IJzerman AP; Jacobson KA; Auchampach JA Purinergic Signal; 2018 Mar; 14(1):59-71. PubMed ID: 29170977 [TBL] [Abstract][Full Text] [Related]
5. Characterization of Dual-Acting A Fisher CL; Fallot LB; Wan TC; Keyes RF; Suresh RR; Rothwell AC; Gao ZG; McCorvy JD; Smith BC; Jacobson KA; Auchampach JA ACS Pharmacol Transl Sci; 2022 Aug; 5(8):625-641. PubMed ID: 35983277 [TBL] [Abstract][Full Text] [Related]
6. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist. Pandey P; Roy KK; Doerksen RJ J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534 [TBL] [Abstract][Full Text] [Related]
7. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000. Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268 [TBL] [Abstract][Full Text] [Related]
8. Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor. Kim Y; de Castro S; Gao ZG; Ijzerman AP; Jacobson KA J Med Chem; 2009 Apr; 52(7):2098-108. PubMed ID: 19284749 [TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of purine and pyrimidine receptors. Jacobson KA; Gao ZG; Göblyös A; Ijzerman AP Adv Pharmacol; 2011; 61():187-220. PubMed ID: 21586360 [TBL] [Abstract][Full Text] [Related]
10. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives. Gao ZG; Kim SG; Soltysiak KA; Melman N; IJzerman AP; Jacobson KA Mol Pharmacol; 2002 Jul; 62(1):81-9. PubMed ID: 12065758 [TBL] [Abstract][Full Text] [Related]
11. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors. Salmaso V; Jacobson KA Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404 [TBL] [Abstract][Full Text] [Related]
12. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study. Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414 [TBL] [Abstract][Full Text] [Related]
14. Development of allosteric modulators of GPCRs for treatment of CNS disorders. Nickols HH; Conn PJ Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101 [TBL] [Abstract][Full Text] [Related]
15. In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators. Yuan J; Jiang C; Wang J; Chen CJ; Hao Y; Zhao G; Feng Z; Xie XQ Molecules; 2022 Jan; 27(2):. PubMed ID: 35056767 [TBL] [Abstract][Full Text] [Related]
16. Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex. Jiang C; He X; Wang Y; Chen CJ; Othman Y; Hao Y; Yuan J; Xie XQ; Feng Z ACS Chem Neurosci; 2023 Feb; 14(3):418-434. PubMed ID: 36692197 [TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of the adenosine family of receptors. Gao ZG; Kim SK; Ijzerman AP; Jacobson KA Mini Rev Med Chem; 2005 Jun; 5(6):545-53. PubMed ID: 15974932 [TBL] [Abstract][Full Text] [Related]
18. Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000. Deganutti G; Cuzzolin A; Ciancetta A; Moro S Bioorg Med Chem; 2015 Jul; 23(14):4065-71. PubMed ID: 25868747 [TBL] [Abstract][Full Text] [Related]
19. Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor. Gao ZG; Kim SK; Gross AS; Chen A; Blaustein JB; Jacobson KA Mol Pharmacol; 2003 May; 63(5):1021-31. PubMed ID: 12695530 [TBL] [Abstract][Full Text] [Related]
20. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity. Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]